PL EN


Preferences help
enabled [disable] Abstract
Number of results
2006 | 54 | 2 | 113-120
Article title

Novel therapies of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter spp. infections: the state of the art

Authors
Content
Title variants
Languages of publication
EN
Abstracts
EN
Gram-negative non-fermenting bacilli, particularly Pseudomonas aeruginosa and Acinetobacter spp., are important opportunistic pathogens in hospitalized patients, contributing to their morbidity and mortality. Recently, a rapid increase in frequency of multidrug-resistant clinical strains is being recorded, making the available therapeutic options very limited. Apart from the development of novel classes of antimicrobials, there is renewed interest in the use of old agents or new combinations of available drugs. Numerous in vitro investigations have been reported on the efficacy of different antimicrobials; however, they should be evaluated in experimental infection models and clinical trials. Novel approaches are being investigated, such as inhibition of virulence factor expression by pathogens or inhibition of their metabolic pathways. The use of bacteriophages, particularly those genetically modified, remains an alternative option in the therapy of infections caused by multidrug-resistant strains. Several vaccines against P. aeruginosa are under development. Apart from therapy with antimicrobial agents, eradication of outbreaks comprises implementation of strict infection control measures and prudent use of antimicrobials.
References
Document Type
REVIEW
Publication order reference
Marta Wroblewska, Department of Medical Microbiology, Medical University of Warsaw, Chalubinskiego 5, 02-004 Warsaw, Poland
YADDA identifier
bwmeta1.element.element-from-psjc-57d87b12-c67b-36e4-a1b1-f7d95437c5d6
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.